Correlation Between Molecular Partners and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and NewAmsterdam Pharma, you can compare the effects of market volatilities on Molecular Partners and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and NewAmsterdam Pharma.
Diversification Opportunities for Molecular Partners and NewAmsterdam Pharma
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Molecular and NewAmsterdam is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Molecular Partners i.e., Molecular Partners and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Molecular Partners and NewAmsterdam Pharma
Given the investment horizon of 90 days Molecular Partners is expected to generate 1.24 times less return on investment than NewAmsterdam Pharma. In addition to that, Molecular Partners is 1.58 times more volatile than NewAmsterdam Pharma. It trades about 0.05 of its total potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.09 per unit of volatility. If you would invest 900.00 in NewAmsterdam Pharma on September 2, 2024 and sell it today you would earn a total of 1,085 from holding NewAmsterdam Pharma or generate 120.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Molecular Partners |
| NewAmsterdam Pharma |
Molecular Partners and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and NewAmsterdam Pharma
The main advantage of trading using opposite Molecular Partners and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |